News
NewsPharma Pulse
Academy
Publications
Partner Perspectives
More
Webcasts
Resources
Conferences
Conference CoverageConference Listing
Events
Videos
VideosPeer Exchange
Podcasts
Editorial PodcastsSponsored Podcasts

Subscribe

  • News
  • Academy
  • Publications
  • Partner Perspectives
  • Webcasts
  • Resources
  • Conferences
  • Events
  • Videos
  • Podcasts
  • Subscribe
  • Brand & Product Security
    • Legal & Regulatory
    • Trade & Brand Protection
    • Traceability
  • Business and Finance
  • Cold Chain
    • Containers & Shippers
    • Software
    • Devices
  • Commercial Channels
  • Data & Technology
    • Real World Data
    • Digitalization
    • Artificial Intelligence
  • Logistics & Transportation
    • Manufacturing & Packaging
    • 3PL
    • Supply Chain
  • Market Access
    • Pricing
    • Commercialization
    • Trade & Channel
  • Opinion
  • Patient Support
    • Patient Assistance Programs
    • HUB Services
    • Adherence
Spotlight -
Digital Editions|
Security|
Asembia AXS25 Summit
Advertisement

Dave Ulhrich, Abbott Labs

Advertisement

Articles by Dave Ulhrich, Abbott Labs

Bringing room-temperature pharma shipping under the 'CRT' umbrella

ByDave Ulhrich, Abbott Labs,TJ Rizzo, Cold Chain Technologies
March 7th 2012

'Controlled room temperature' (CRT) shipping is being transformed from standard shipping processes to engineered, compliance-ready processes and materials

Advertisement

Latest Updated Articles

  • Bringing room-temperature pharma shipping under the 'CRT' umbrella
    Bringing room-temperature pharma shipping under the 'CRT' umbrella

    Published: March 7th 2012 | Updated:



Advertisement
Advertisement

Trending on Pharmaceutical Commerce

1

Mark Cuban Confirms Cost Plus Drugs Partnership

2

BioNTech Launches Public Exchange Offer for CureVac in $1.25B All-Stock Deal

3

Why Rising Complexity and R&D Costs Are Fueling Specialty Drug Spending

4

The Unsung Allies Helping Patients Navigate Specialty Drug Access

5

Pharma Pulse: MJH Life Sciences Expands into Health Systems, Novo Nordisk Board Shakeup Moves Markets, and Mark Cuban Grows Cost Plus Drugs Network

  • About Us
  • Advertise
  • Editorial
  • Contact Us
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us